Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1

REFERENCES

• Banai, S., D. Shweiki, A. Pinson, M. Chandra, G. Lazarovici, and E. Keshet. 1994. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc. Res. 28:1176–1179.
   PubMed Web of Science ®Google Scholar
• Beck, I., S. Ramirez, R. Weinmann, and J. Caro. 1991. Enhancer element at the 3′-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J. Biol. Chem. 266:15563–15566.
   PubMed Web of Science ®Google Scholar
• Beck, I., R. Weinmann, and J. Caro. 1993. Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 82:704–711.
   PubMed Web of Science ®Google Scholar
• Burbach, K. M., A. Poland, and C. A. Bradfield. 1992. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. USA 89:8185–8189.
   PubMed Web of Science ®Google Scholar
• Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Bio-chem. 162:156–159.
   Google Scholar
• Dolwick, K. M., H. I. Swanson, and C. A. Bradfield. 1993. In vitro analysis of Ah receptor domains involved in ligand-activated transcription. Proc. Natl. Acad. Sci. USA 90:8566–8570.
   PubMed Web of Science ®Google Scholar
• Ebert, B. L., J. D. Firth, and P. J. Ratcliffe. 1995. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences. J. Biol. Chem. 270:29083–29089.
   PubMed Web of Science ®Google Scholar
• Fandrey, J., and H. F. Bunn. 1993. In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood 81:617–623.
   PubMed Web of Science ®Google Scholar
• Ferrara, N., and W. J. Henzel. 1989. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Bio-chem. Biophys. Res. Commun. 161:851–858.
   PubMed Web of Science ®Google Scholar
• Ferrara, N., K. Houck, L. Jakman, and D. W. Leung. 1992. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol. Rev. 13:18–32.
   PubMed Web of Science ®Google Scholar
• Finkenzeller, G., A. Technau, and D. Marme. 1995. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem. Biophys. Res. Commun. 208:432–439.
   PubMed Web of Science ®Google Scholar
• Firth, J. D., B. L. Ebert, C. W. Pugh, and P. J. Ratcliffe. 1994. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc. Natl. Acad. Sci. USA 91:6496–6500.
   PubMed Web of Science ®Google Scholar
• Firth, J. D., B. L. Ebert, and P. J. Ratcliffe. 1995. Hypoxic regulation of lactate dehydrogenase A: interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 270:21021–21027.
   PubMed Web of Science ®Google Scholar
• Folkman, J., and Y. Shing. 1992. Angiogenesis. J. Biol. Chem. 267:10931–10934.
   PubMed Web of Science ®Google Scholar
• Gleadle, J. M., B. L. Ebert, J. D. Firth, and P. J. Ratcliffe. 1995. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am. J. Physiol. 268:C1362–C1368.
   PubMed Web of Science ®Google Scholar
• Goldberg, M. A., C. C. Gaut, and H. F. Bunn. 1991. Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscrip-tional events. Blood 77:271–277.
   PubMed Web of Science ®Google Scholar
• Goldberg, M. A., and T. J. Schneider. 1994. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269:4355–4359.
   PubMed Web of Science ®Google Scholar
• Gospodarowicz, D., J. A. Abraham, and J. Schilling. 1989. Isolation of a vascular endothelial cell mitogen produced by pituitary-derived folliculo-stellate cells. Proc. Natl. Acad. Sci. USA 86:7311–7315.
   PubMed Web of Science ®Google Scholar
• Hoffman, E. C., H. Reyes, F.-F. Chu, F. Sander, L. H. Conley, B. A. Brooks, and O. Hankinson. 1991. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252:954–958.
   PubMed Web of Science ®Google Scholar
• Ikeda, E., M. G. Achen, G. Breier, and W. Risau. 1995. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270:19761–19766.
   PubMed Web of Science ®Google Scholar
• Iyer, N. V., and G. L. Semenza. 1996. Unpublished data.
   Google Scholar
• Jelkmann, W. 1992. Erythropoietin: structure, control of production, and function. Physiol. Rev. 72:449–489.
   PubMed Web of Science ®Google Scholar
• Jiang, B.-H., E. Rue, G. L. Wang, R. Roe, and G. L. Semenza. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem., in press.
   Google Scholar
• Klagsbrun, M., and S. Soker. 1993. VEGF/VPF: the angiogenesis factor found? Curr. Biol. 3:699–702.
   Google Scholar
• Krantz, S. B. 1991. Erythropoietin. Blood 77:419–434.
   PubMed Web of Science ®Google Scholar
• Ladoux, A., and C. Frelin. 1993. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochem. Biophys. Res. Commun. 195:1005–1010.
   PubMed Web of Science ®Google Scholar
• Lee, P., B.-H. Jiang, G. L. Semenza, J. Alam, and A. Choi. Unpublished data.
   Google Scholar
• Leung, D. W., G. Cachianes, W. J. Kuang, D. V. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306–1309.
   PubMed Web of Science ®Google Scholar
• Levy, A. P., N. S. Levy, and M. A. Goldberg. 1996. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271:2746–2753.
   PubMed Web of Science ®Google Scholar
• Levy, A. P., N. S. Levy, J. Loscalzo, A. Calderone, N. Takahashi, K.-T. Yeo, G. Koren, W. S. Colucci, and M. A. Goldberg. 1995. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ. Res. 76:758–766.
   PubMed Web of Science ®Google Scholar
• Levy, A. P., N. S. Levy, S. Wegner, and M. A. Goldberg. 1995. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270:13333–13340.
   PubMed Web of Science ®Google Scholar
• Li, H., L. Dong, and J. P. Whitlock, Jr. 1994. Transcriptional activation function of the mouse Ah receptor nuclear translocator. J. Biol. Chem. 269:29098–28105.
   Google Scholar
• Liu, Y., S. R. Cox, T. Morita, and S. Kourembanas. 1995. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ. Res. 77:638–643.
   PubMed Web of Science ®Google Scholar
• Lowenstein, C., and G. L. Semenza. Unpublished data.
   Google Scholar
• Ma, Q., L. Dong, and J. P. Whitlock, Jr. 1995. Transcriptional activation by the mouse Ah receptor: interplay between multiple stimulatory and inhibitory functions. J. Biol. Chem. 270:12697–12703.
   PubMed Web of Science ®Google Scholar
• Madan, A., and P. T. Curtin. 1993. A 24-base-pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. USA 90:3928–3932.
   PubMed Web of Science ®Google Scholar
• Martin, C., A. Yu, B.-H. Jiang, A. R. Hohimer, L. E. Davis, and G. L. Semenza. Unpublished data.
   Google Scholar
• Melillo, G., T. Musso, A. Sica, L. S. Taylor, G. W. Cox, and L. Varesio. 1995. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182:1683–1693.
   PubMed Web of Science ®Google Scholar
• Miller, J. W., A. P. Adamis, D. T. Shima, P. A. D’Amore, R. S. Moulton, M. S. O’Reilly, J. Folkman, H. F. Dvorak, L. F. Brown, B. Berse, T.-K. Yeo, and K.-T. Yeo. 1994. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol. 145:574–584.
   PubMed Web of Science ®Google Scholar
• Minchenko, A., S. Salceda, T. Bauer, and J. Caro. 1994. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell. Mol. Biol. Res. 40:35–39.
   PubMedGoogle Scholar
• Nomura, M., S. Yamagishi, S. Harada, Y. Hayashi, T. Yamashima, J. Ya-mashita, and H. Yamamoto. 1995. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 270:28316–28324.
   PubMed Web of Science ®Google Scholar
• Pierce, E. A., R. L. Avery, E. D. Foley, L. P. Aiello, and L. E. H. Smith. 1995. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92:905–909.
   PubMed Web of Science ®Google Scholar
• Plate, K. H., G. Breier, B. Millauer, A. Ullrich, and W. Risau. 1993. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53:5822–5827.
   PubMed Web of Science ®Google Scholar
• Plate, K. H., G. Breier, H. A. Weich, and W. Risau. 1992. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (London) 359:845–848.
   PubMed Web of Science ®Google Scholar
• Pugh, C. W., C. C. Tan, R. W. Jones, and P. J. Ratcliffe. 1991. Functional analysis of an oxygen-regulated transcriptional enhancer lying 3′ to the mouse erythropoietin gene. Proc. Natl. Acad. Sci. USA 88:10553–10557.
   PubMed Web of Science ®Google Scholar
• Ratcliffe, P. J. 1994. Molecular biology of erythropoietin. Kidney Int. 44:887–904.
   Google Scholar
• Reisz-Porszasz, S., M. R. Probst, B. N. Fukunaga, and O. Hankinson. 1994. Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT). Mol. Cell. Biol. 14:6075–6086.
   PubMed Web of Science ®Google Scholar
• Reyes, H., S. Reisz-Porszasz, and O. Hankinson. 1992. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256:1193–1195.
   PubMed Web of Science ®Google Scholar
• Schuster, S. J., E. V. Badiavas, P. Costa-Giomi, R. Weinmann, A. J. Erslev, and J. Caro. 1987. Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure. Blood 73:13–16.
   Google Scholar
• Semenza, G. L., S. Leung, B.-H. Jiang, and A. Giallongo. Unpublished data.
   Google Scholar
• Semenza, G. L., M. K. Nejfelt, S. M. Chi, and S. E. Antonarakis. 1991. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA 88:5680–5684.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L., P. H. Roth, H.-M. Fang, and G. L. Wang. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:23757–23763.
   PubMed Web of Science ®Google Scholar
• Semenza, G. L., and G. L. Wang. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12:5447–5454.
   PubMed Web of Science ®Google Scholar
• Shima, D. T., M. Kuroki, U. Deutsch, Y.-S. Ng, A. P. Adamis, and P. A. D’Amore. 1996. The mouse gene for vascular endothelial growth factor: genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271:3877–3883.
   PubMed Web of Science ®Google Scholar
• Shweiki, D., A. Itin, D. Soffer, and E. Keshet. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London) 359:843–845.
   PubMed Web of Science ®Google Scholar
• Sogawa, K., R. Nakano, A. Kobayashi, Y. Kikuchi, N. Ohe, N. Matsushita, and Y. Fujii-Kuriyama. 1995. Possible function of Ah receptor nuclear translocator (Arnt) homodimer in transcriptional regulation. Proc. Natl. Acad. Sci. USA 92:1936–1940.
   PubMed Web of Science ®Google Scholar
• Stein, I., M. Neeman, D. Shweiki, A. Itin, and E. Keshet. 1995. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell. Biol. 15:5363–5368.
   PubMed Web of Science ®Google Scholar
• Swanson, H. I., W. K. Chan, and C. A. Bradfield. 1995. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J. Biol. Chem. 270:26292–26302.
   PubMed Web of Science ®Google Scholar
• Tan, C. C., and P. J. Ratcliffe. 1991. Effect of inhibitors of oxidative phosphorylation on erythropoietin mRNA in isolated perfused rat kidneys. Am. J. Physiol. 261:F982–F987.
   PubMed Web of Science ®Google Scholar
• Tischer, E., S. R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J. C. Fiddes, and J. A. Abraham. 1991. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:11947–11954.
   PubMed Web of Science ®Google Scholar
• Wang, G. L., B.-H. Jiang, E. A. Rue, and G. L. Semenza. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 92:5510–5514.
   PubMed Web of Science ®Google Scholar
• Wang, G. L., and G. L. Semenza. 1993. General involvement of hypoxia-inducible factor in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90:4304–4308.
   PubMed Web of Science ®Google Scholar
• Wang, G. L., and G. L. Semenza. 1993. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268:21513–21518.
   PubMed Web of Science ®Google Scholar
• Wang, G. L., and G. L. Semenza. 1993. Desferoxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:3610–3615.
   PubMed Web of Science ®Google Scholar
• Wang, G. L., and G. L. Semenza. 1995. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270:1230–1237.
   PubMed Web of Science ®Google Scholar
• Wenger, R. H., A. Rolfs, H. H. Marti, C. Bauer, and M. Gassmann. 1995. Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. J. Biol. Chem. 270:27865–27870.
   PubMedGoogle Scholar
• Whitelaw, M. L., J.-A. Gustafsson, and L. Poellinger. 1994. Identification of transactivation and repression functions of the dioxin receptor and its basic helix-loop-helix/PAS partner factor Arnt: inducible versus constitutive modes of regulation. Mol. Cell. Biol. 14:8343–8355.
   PubMed Web of Science ®Google Scholar
• Wiener, C. M., G. Booth, and G. L. Semenza. Unpublished data.
   Google Scholar